News Downloads About Us Contact Us
Paper Titles
Review on Pharmacological Effects of Plectranthus forskohlii (Willd) Briq
p.1
Screening and Characterization of Fibrinolytic Protease Producing Bacillus circulans from Mangrove Sediments Pitchavaram, South East Coast of India
p.10
Nucleic Acid Content in Tissue of the Fish N. notopterus Collected from Different Aquatic Bodies
p.17
Characterization and Analyses of Hydrophobic Clusters, Acetylation and Myristoylation Sites in Plant Glutathione Peroxidase Sequences
p.27
Shoot Growth in Typha angustifolia l. and Typha latifolia l. in the Kokemäenjoki River Delta Western Finland
p.34
Morphological Variation Assessment in Different Accessions of Plectranthus forskohlii (Willd) Briq. from South India
p.47

Review on Pharmacological Effects of Plectranthus forskohlii (Willd) Briq

Retracted:

Removed due to plagiarism

Article Preview

Abstract:

Plectranthus forskohlii (Willd). Briq. (Syn: Coleus forskohlii) is an important indigenous medicinal plant in India. It has been used in traditional Ayurveda medicine for curing various disorders and this is the only source of the diterpenoid forskolin. Forskolin is used for the treatment of eczema, asthma, psoriasis, cardiovascular disorders and hypertension, where decreased intracellular cAMP level is believed to be a major factor in the development of the disease process. A comprehensive account of the morphology, medicinal uses, phytochemistry, pharmacological activities, analytical methods and biotechnological approaches for forskolin production reported are included in view of the many recent findings of importance on this plant.

By email View Pdf

Info:

Periodical:

International Letters of Natural Sciences (Volume 28)

Pages:

1-9

DOI:

https://doi.org/10.56431/p-g7091g

Online since:

November 2014

Authors:

Ganapathy Murugan Alagu Lakshmanan, Selvarasuvasuki Manikandan

Keywords:

Plectranthus forskohlii, Forskolin, Pharmacology, Phytochemistry

Export:

RIS, BibTeX

Permissions:

Creative Commons CC BY 4.0

Share:

Citation:

References

[1] Adnot S, Desmier M, Ferry N, Hanoune J and Sevenet T. Forskolin – a powerful inhibitor of human platelet aggregation. Biochem. Pharmacol. 1982; 31:4071-4074.

DOI: 10.1016/0006-2952(82)90659-1

Google Scholar

[2] Agarwal KC and Parks RE, Forskolin: a potential antimetastatic agent. Int. J. Cancer. 1983; 32:801-804.

DOI: 10.1002/ijc.2910320622

Google Scholar

[3] Ammon HP and Kemper FH, Ayurveda: 3000 years of Indian traditional medicine. Med. Welt. 1982; 33:148-153.

Google Scholar

[4] Ammon HP and Muller AB, Forskolin: from an Ayurvedic remedy to a modern agent. Planta. Med.1985; 6:473-477.

DOI: 10.1055/s-2007-969566

Google Scholar

[5] Bailey LH. Standard Cyclopedia of Horticulture. 1942; Macmillan, New York.

Google Scholar

[6] Bauer K, Dietersdorder F, Sertl K, Kaik B and Kaik G, Pharmacodynamic effects of inhaled dry powder formulations of fenoterol and colforsin in asthma. Clin. Pharmacol. Ther.; 1993; 53:76-83.

DOI: 10.1038/clpt.1993.11

Google Scholar

[7] Brubaker RF, Carlson KH, Kullerstrand LJ and Mclaren JW. Topical forskolin (colforsin) and aqueous flow in humans. Arch Ophthalmol.; 1987; 105:637-641.

DOI: 10.1001/archopht.1987.01060050055037

Google Scholar

[8] Bruka JF. Forskoli: Its chemical biological and medical potential. In: Proc. Int. Symp. Forskolin, Hoechst India Ltd., Bombay; p.1986; 117-136.

Google Scholar

[9] Chowdhary AR, Sharma ML. GC-MS investigations on the essential oil from Coleus forskohlii Briq. Indian Perfumer 1998; 42:15-16.

Google Scholar

[10] De Souza NJ and Shah V. Forskolin – an adenylatecyclase activating drug from an Indian herb. Econ. Med. Plant Res.; 1988; 2:1-16.

Google Scholar

[11] De Souza NJ, Dohadwalla AN, Reden J. Forskolin: a labdane diterpenoid with anti-hypertensive, positive inotropic, platelet aggregation inhibitory, and adenylate cyclase activating properties. Med. Res. Rev. 1983; 3:201-219.

DOI: 10.1002/med.2610030205

Google Scholar

[12] Demetzos C, Kolocouris A, Anastasaki T. A simple andrapid method for the differentiation of C-13 manoyloxide epimersin biologically important samples using GC-MS analysis supported with NMR spectroscopy and computational chemistry results. Bio Org Med Chem Lett .2002; 12:3605-3609.

DOI: 10.1016/s0960-894x(02)00792-8

Google Scholar

[13] Dubey MP, Srimal RC, Nityanand S, Dhawan BN. Pharmacological studies on coleonol, a hypotensive diterpene from Coleus forskohlii. J. Ethnopharmacol. 1981; 3:1-13.

DOI: 10.1016/0378-8741(81)90010-6

Google Scholar

[14] Han LK, Morimoto C, Yu RH, Okuda H. Effects of Coleus forskohlii on fat storage in ovariectomized rats. Yakugaku Zasshi. 2005; 125:449-453.

DOI: 10.1248/yakushi.125.449

Google Scholar

[15] Henderson S, Magu B, Rasmussen C, Lancaster S, Kerksick C, Smith P, Melton C, Cowan P, Greenwood M, Earnest C, Almada A, Milnor P, Magrans T, Bowden R, Ounpraseuth S, Thomas A, Kreider RB. Effects of Coleus forskohlii supplementation on body composition and hematological profiles in mildly overweight women. J. Int. Soc. Sports Nutr. 2005; 9:54-62.

DOI: 10.1186/1550-2783-2-2-54

Google Scholar

[16] Hosono M, Takahira T, Fujita A, Fujihara R, Ishizuka O, Ohio I, Tatee T, Nakamura K. Cardiovascular effects of NICH 477, a novel potent water soluble forskolin derivative. Eur. J. Pharmacol. 1990; 183:2110.

DOI: 10.1016/0014-2999(90)93628-4

Google Scholar

[17] Inamdar PK, Dornauer H, deSouza NJ. GLC method for assay of forskolin, a novel positive inotropic and blood pressure-lowering agent. J. Pharm. Sci. 1980; 69:1449-1451.

DOI: 10.1002/jps.2600691230

Google Scholar

[18] Inamdar PK, Kanitkar PV, Reden J, deSouza NJ. Quantitative determination of forskolin by TLC and HPLC. Planta Med. 1984; 50:30-34.

DOI: 10.1055/s-2007-969614

Google Scholar

[19] Lee PY, Podos SM, Serle JB, Camras CB and Severin CH. Intraocular pressure effects of multiple doses of drugs applied to glaucomatous monkey eyes. Arch Ophthalmol.; 1987; 105:249-252.

DOI: 10.1001/archopht.1987.01060020103038

Google Scholar

[20] Marone G, Columbo M, Triggiani M, Cirillo R, Genovese A and Formisano S. Inhibition of IgE-mediated release of histamine and peptide leukotriene from human basophils and mast cells by forskolin. Biochem. Pharmacol.; 1987; 36:13-20.

DOI: 10.1016/0006-2952(87)90377-7

Google Scholar

[21] Rajangam J. Studies on the effect of planting methods and growth regulators on growth, tuber development, yield and quality, and standardization of post-harvest technology of Coleus (Coleus forskohlii Briq.)". Ph. D Thesis, Tamil Nadu Agricultural University, Coimbatore. 2005.

Google Scholar

[22] Rupp RH, De Souza NJ and Dohadwalla AN. Forskolin: Its chemical, biological and medical potential. In: Proc. Int. Symp. Forskolin., Hoechst India Limited, Bombay.; 1986; pp.19-30.

Google Scholar

[23] Saksena AK, Green MJ, Shue HJ. Identity of coleonol with forskolin: Structure revision of a base-catalyzed rearrangement product. Tetra hedron Lett. 1985; 26:551-554.

DOI: 10.1016/s0040-4039(00)89145-5

Google Scholar

[24] Saleem AM, Dhasan PB, Rafiullah MR. Simple and rapid method for the isolation of forskolin from Coleus forskohlii by charcoal column chromatography. J Chromatograph. 2006; 1101:313-314.

DOI: 10.1016/j.chroma.2005.11.032

Google Scholar

[25] Schaneberg BT, Khan IA. Quantitative analysis of forskolin in Coleus forskohlii (Lamiaceae) by reversed-phase liquid chromatography. J AOAC Int. 2003; 86: 467-470.

DOI: 10.1093/jaoac/86.3.467

Google Scholar

[26] Shah V, Bhat SV, Bajwa BS, Dornaeur H, De Souza NJ. The occurrence of forskolin in Labiatae. Planta Medica. 1980; 39:183-185.

DOI: 10.1055/s-2008-1074923

Google Scholar

[27] Shan Y, Xu L, Lu Y, Wang X, Zheng Q, Kong L, Niwa M. Diterpenes from Coleus forskohlii. Chem Pharm Bull. 2008; 56:52-56.

DOI: 10.1248/cpb.56.52

Google Scholar

[28] ShanY, Wang X, Zhou X, Kong L, Niwa M. Two minor diterpene glycosides and aneudesman sesquiterpene from Coleus forskohlii. Chem. Pharm. Bull. 2007; 55:376-81.

DOI: 10.1248/cpb.55.376

Google Scholar

[29] Shen YH, Xu YL. Two new diterpenoids from Coleus forskohlii. J. Asian Nat. Prod. Res.2005; 7:811-815

DOI: 10.1080/1028602042000204135

Google Scholar

[30] Siegl AM, Daly JW and Smith JB. Inhibition of aggregation and stimulation of cyclic AMP generation in intact human platelets by the diterpeneforskolin. Mol Pharmacol.; 1982; 21:680-687.

Google Scholar

[31] Valdes LJ, Mislankar SG, Paul AG. Coleus barbatus (C. forskohlii) (Lamiaceae) and the potential new drug forskolin (Coleonol). Econ. Bot. 1987; 44:474-483.

DOI: 10.1007/bf02908139

Google Scholar

[32] Wu HZ, Yang QR, Yang YF, Liu YW. Studies on HPLC-ELSD fingerprint of the Coleus forskohlii introduced in Tongcheng. Zhong Yao Cai. 2007; 30:1370-1374.

Google Scholar

[33] Wysham DG, Brotherton AF and Heistad DD. Effects of forskolin on cerebral blood flow: implications for a role of adenylatecyclase. Stroke; 1986; 17:1299-1303.

DOI: 10.1161/01.str.17.6.1299

Google Scholar

[34] Xu LL, Lu J, Li WJ, Kong LY. Studies on the chemical constituents in root of Coleus forskohlii. Zhongguo ZhongYao ZaZhi. 2005; 30:1753-1755.

Google Scholar

[35] Yanagihara H, Sakata R, Shoyama Y, Murakami H. Rapid analysis of small samples containing forskolin using monoclonal antibodies. Planta Med. 1996; 62:169-172. ( Received 14 October 2014; accepted 22 October 2014 )

DOI: 10.1055/s-2006-957844

Google Scholar

© 2025 AOA Academic Open Access Ltd, Cyprus. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For open access content, terms of the Creative Commons licensing CC-BY are applied. AcademicOA.com is a registered trademark of AOA Academic Open Access Ltd, Cyprus.